Experiment 70635
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV |
| Organism | Empty organism |
| Citation | ROUESSE,JG: LE CHEVALIER,T: CAILLE,P: MONDESIR,JM: SANCHO-GARNIER,H: MAY-LEVIN,F: SPIELMANN,M: DE JAGER,R: AMIEL,JL:. (1985). PHASE II STUDY OF ELLIPTINIUM IN ADVANCED BREAST CANCER.. 69(6) |
| Amount utilized | |
| Compound isolated | |
| Disease | IN THIS PHASE II STUDY,74 PATIENTS WITH ADVANCED BREAST CANCER WERE TREATED ONCE A WEEK FOR 6 WEEKS WITH INTERVALS,THEN INCREASING TO 2-4 WEEKS. OF 63 EVALUABLE PATIENTS,THERE WERE 2 COMPLETE RESPONSES,10 PARTIAL RESPONSES AND 10 MINOR RESPONSES. MEAN DURATION OF RESPONSE WAS 22 WEEKS. HEMOLYSIS WAS SEEN IN 5 PATIENTS AND IS CONSIDERED THE DOSE LIMITING TOXICITY. THERE WERE NO CASES OF BONE MARROW TOXICITY. IRREVERSIBLE RENAL TOXICITY WAS SEEN IN ONE OF TEN PATIENTS WHO HAD A CUMULATIVE DOSE OF MORE THAN 2000 MG. |
| Dose amount | 100.0 MG |
| Number | 1 |
| Qualitative result | EQUIVOCAL |
| Animal | HUMAN ADULT |
| Per unit | SQ M BODY SURFACE |
| Dose expression | DOSE |
| Gender | FEMALE |